methoxyhydroxyphenylglycol has been researched along with n(6)-cyclopentyladenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, PJ; Toms, NJ | 1 |
| Mackie, K; Min, KT; Straiker, A | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
Group 1 mGlu receptors elevate [Ca2+]i in rat cultured cortical type 2 astrocytes: [Ca2+]i synergy with adenosine A1 receptors.
Topics: Adenosine; Animals; Animals, Newborn; Astrocytes; Calcium; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Methoxyhydroxyphenylglycol; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Metabotropic Glutamate; Receptors, Purinergic P1; Thapsigargin | 1999 |
Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons.
Topics: Adenosine; Animals; Baclofen; Data Interpretation, Statistical; Electrophysiological Phenomena; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; GABA Agonists; Hippocampus; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neurons; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Synapses | 2013 |